CELH
Celsius Holdings, Inc.
CELH has the edge over SAM overall, supported by stronger fundamentals and stronger valuation.
SAM
The Boston Beer Company, Inc.
SAM has slightly lower modeled downside risk, despite its lower overall score.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
SAM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Stable | |
| Strong |
SAM's balance sheet is currently strong, and its revenue and cash flow are stable, but its profitability is weak.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
SAM PE Valuation
SAM has no meaningful PE right now: it lost money over the past year.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
CELH has the edge over SAM on the outlook, with more favorable revenue expectations.
SAM Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| Low |
Analysts expect SAM's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH has the edge over SAM on earnings quality, reporting a profit while its opponent remains loss making.
SAM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $10.51 | — |
| Q3 2026 | -$6.68 | -177% |
| Q2 2026 | -$6.64 | -192% |
| Q1 2026 | -$6.15 | -200% |
| Q4 2025 | $9.89 | +95% |
| Q3 2025 | $8.63 | +27% |
| Q2 2025 | $7.24 | -5.4% |
| Q1 2025 | $6.18 | -23% |
| Q4 2024 | $5.06 | -19% |
SAM has swung to a loss: it lost $6.68 per share over the past year, after a profit the year before.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over SAM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over SAM on profitability, with a higher operating margin.
SAM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $520.1M | -3.2% |
| Q2 2026 | $568.3M | -3.3% |
| Q1 2026 | $433.9M | -4.4% |
| Q4 2025 | $385.7M | -4.1% |
| Q3 2025 | $537.5M | -11% |
| Q2 2025 | $587.9M | +1.5% |
| Q1 2025 | $453.9M | +6.5% |
| Q4 2024 | $402.3M | +2.2% |
SAM's revenue fell from its 2022 peak and has held roughly level since: $520M last quarter, down 3.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | -0.7 points |
| Q2 2026 | 12% | -1.5 points |
| Q1 2026 | -44% | -51 points |
| Q4 2025 | -8.6% | +5.4 points |
| Q3 2025 | 12% | +4 points |
| Q2 2025 | 14% | +1.7 points |
| Q1 2025 | 7.4% | +3.8 points |
| Q4 2024 | -14% | -7.3 points |
SAM's operating margin was 11% last quarter, down 0.7 points from the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
SAM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $68.3M | -24% |
| Q2 2026 | $127.5M | +14% |
| Q1 2026 | -$32.8M | -$24.8M |
| Q4 2025 | $22.1M | +20% |
| Q3 2025 | $89.2M | -10% |
| Q2 2025 | $112.2M | +48% |
| Q1 2025 | -$8M | +$12.6M |
| Q4 2024 | $18.4M | +5.5% |
SAM has the edge over CELH on cash flow, with more consistent year-over-year improvement.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has 255M diluted shares, down 1.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
SAM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.3% | -134K shares |
| 1 year | -5.6% | -606K shares |
| 3 years | -16% | -2M shares |
| 5 years | -17% | -2.1M shares |
| Available history | -14% | -1.7M shares |
SAM has the edge over CELH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $25.4M |
| Q2 2026 | $26.6M |
| Q1 2026 | $23.3M |
| Q4 2025 | $50M |
| Q3 2025 | $50.8M |
| Q2 2025 | $52.2M |
| Q1 2025 | $49.4M |
| Q4 2024 | $62.7M |
SAM spent $125M buying back its own shares over the past year, down 42% from the year before.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
SAM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -16.7x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q3 2025 | -1.2x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -0.8x | Net Cash |
| Q4 2024 | -1.3x | Net Cash |
| Q3 2024 | -1.3x | Net Cash |
| Q2 2024 | -1.0x | Net Cash |
SAM has more cash than debt.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
SAM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.6 | Neutral |
| Stochastic | 86.2 | Overbought |
SAM's weekly RSI is 64 (neutral) and its Stochastic is 86 (overbought).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
SAM PE vs Consumer Defensive Sector
| Metric | SAM | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 19x | — |
SAM has no meaningful PE right now: it lost money over the past year.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
SAM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $190.8 | 15% above |
| 20 week MA | $184.2 | 19% above |
| 50 week MA | $201.0 | 9.3% above |
| 100 week MA | $214.9 | 2.2% above |
| 200 week MA | $267.8 | 18% below |
SAM has the edge over CELH on trend strength, trading above more of its moving averages.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
SAM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $378.8 | $1,014.9 | +168% |
| 2021 | $1,014.9 | $524.9 | -48% |
| 2022 | $524.9 | $336.0 | -36% |
| 2023 | $336.0 | $345.6 | +2.8% |
| 2024 | $345.6 | $301.1 | -13% |
| 2025 | $301.1 | $197.1 | -35% |
| 2026 YTD | $197.1 | $219.6 | +11% |
SAM has the edge over CELH on returns for 2026, with the stronger performance.